Replies to post #3143 on Acadia Pharmaceuticals Inc. (ACAD)

[IanFromSI]

- If you really need to go all the way back to June 21st, here's another analyst on that same day.


ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from JMP Securities
June 21 2022 - 08:26AM
TipRanks

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of $23.00. The company's shares closed last Thursday at $19.51.

Currently, the analyst consensus on ACADIA Pharmaceuticals is a Moderate Buy with an average price target of $27.17, a 39.4% upside from current levels.
https://www.tipranks.com/news/blurbs/acadia-pharmaceuticals-acad-gets-a-buy-rating-from-jmp-securities?utm_source=advfn.com&utm_medium=referral